Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nicholas J. Mellor"'
Autor:
Peter T. Skidmore, Emily A. Kaelin, LaRinda A. Holland, Rabia Maqsood, Lily I. Wu, Nicholas J. Mellor, Joy M. Blain, Valerie Harris, Joshua LaBaer, Vel Murugan, Efrem S. Lim
Publikováno v:
Emerging Infectious Diseases, Vol 27, Iss 10, Pp 2718-2720 (2021)
Genomic surveillance can provide early insights into new circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. While conducting genomic surveillance (1,663 cases) from December 2020–April 2021 in Arizona, USA, we detect
Externí odkaz:
https://doaj.org/article/6f5398b9ebb1492e938bccc83117639e
Autor:
Steven C. Holland, Ajeet Bains, LaRinda A. Holland, Matthew F. Smith, Regan A. Sullins, Nicholas J. Mellor, Alexis W. Thomas, Nathaniel Johnson, Vel Murugan, Efrem S. Lim
Publikováno v:
Viruses, Vol 14, Iss 6, p 1316 (2022)
As the SARS-CoV-2 virus evolves, mutations may result in diminished sensitivity to qRT-PCR diagnostic assays. We investigated four polymorphisms circulating in the SARS-CoV-2 Delta lineage that result in N gene target failure (NGTF) on the TaqPath CO
Externí odkaz:
https://doaj.org/article/1cfaf753e9f84c58a84062e107cb5bf4
Autor:
Valerie Harris, LaRinda A Holland, Nicholas J Mellor, Joshua LaBaer, Efrem S. Lim, Joy M Blain, Rabia Maqsood, Lily I. Wu, Vel Murugan, Peter T Skidmore, Emily A Kaelin
Publikováno v:
Emerging Infectious Diseases
Emerging Infectious Diseases, Vol 27, Iss 10, Pp 2718-2720 (2021)
Emerging Infectious Diseases, Vol 27, Iss 10, Pp 2718-2720 (2021)
Genomic surveillance can provide early insights into new circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. While conducting genomic surveillance (1,663 cases) from December 2020–April 2021 in Arizona, USA, we detect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0926fc2000c0fab306b3aff3b47908d2
http://europepmc.org/articles/PMC8462350
http://europepmc.org/articles/PMC8462350
Autor:
LaRinda A Holland, Efrem S. Lim, Lily I. Wu, Peter T Skidmore, Valerie Harris, Rabia Maqsood, Nicholas J Mellor, Joy M Blain, Emily A Kaelin, Vel Murugan, Joshua LaBaer
SARS-CoV-2 is locked in a high-stakes arms race between the dynamics of rising population immunity and escape mutations. The E484K mutation in the spike protein reduces neutralization by post-vaccination sera and monoclonal antibody therapeutics. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9db7a69648cef450d47f312e80cdeed
https://doi.org/10.1101/2021.03.26.21254367
https://doi.org/10.1101/2021.03.26.21254367
